Wall Street Zen Upgrades Pulmonx (NASDAQ:LUNG) to “Hold”

Pulmonx (NASDAQ:LUNG – Get Free Report) was upgraded by analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued on Saturday. Several other research firms have also recently issued reports on LUNG. Canaccord Genuity Group decreased their target price on shares of Pulmonx from $6.00 to $5.00 [...]